摘要: Pain is commonly categorized into two diverse groups: acute pain, characterized by early onset and last for a very short time; while chronic prolonged pain least 3 months’ duration. Timely immediate management of critical in reducing its aggravation to pain. There has been successful application nano-technology, nano-medicine the treatment both clinical experimental studies like fabrication nano-formulated liposomes deliver drugs therapy, formulation non- steroidal anti-inflammatory (NSAIDs). However safety issues related with NSAIDs have impelled design new drug formulations that reduces side effects sustain efficacy. This review will give concise summary on available designed management.
thieme-connect.de参考文章(53)
Piotr Głuszko, Aneta Bielińska, Non-steroidal anti-inflammatory drugs and the risk of cardiovascular diseases: are we going to see the revival of cyclooxygenase-2 selective inhibitors? Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine. ,vol. 119, pp. 231- 235 ,(2009) , 10.20452/PAMW.662
SC Lewis, MJS Langman, Joan‐Ramon Laporte, John NS Matthews, Michael D Rawlins, Bengt‐Erik Wiholm, None, Dose–response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data British Journal of Clinical Pharmacology. ,vol. 54, pp. 320- 326 ,(2002) , 10.1046/J.1365-2125.2002.01636.X
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials The Lancet. ,vol. 382, pp. 769- 779 ,(2013) , 10.1016/S0140-6736(13)60900-9
Garen Manvelian, Stephen Daniels, Allan Gibofsky, A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac. Pain Medicine. ,vol. 13, pp. 1491- 1498 ,(2012) , 10.1111/J.1526-4637.2012.01479.X
Kiran Chaturvedi, Kuntal Ganguly, Mallikarjuna N. Nadagouda, Tejraj M. Aminabhavi, Polymeric hydrogels for oral insulin delivery. Journal of Controlled Release. ,vol. 165, pp. 129- 138 ,(2013) , 10.1016/J.JCONREL.2012.11.005
Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly, Gian Sberna, Ben J. Boyd, Mark Williamson, David J. Owen, Christopher J.H. Porter, A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems Nanomedicine: Nanotechnology, Biology and Medicine. ,vol. 8, pp. 103- 111 ,(2012) , 10.1016/J.NANO.2011.05.013
Mark Kowalski, Douglas G Stoker, Charles Bon, Keith A Moore, Stephen E Boesing, A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy. American Journal of Therapeutics. ,vol. 17, pp. 460- 468 ,(2010) , 10.1097/MJT.0B013E3181AA3EDA
Hongjun Li, Hui Qiao, Hongjie Lu, Changqi Liu, Evaluation of the peripheral analgesic effect of sufentanil lipid nanoparticles Journal of Anesthesia. ,vol. 28, pp. 702- 707 ,(2014) , 10.1007/S00540-014-1795-9
Patricia McGettigan, David Henry, Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLOS Medicine. ,vol. 8, ,(2011) , 10.1371/JOURNAL.PMED.1001098
Nicholas Moore, Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. Clinical Drug Investigation. ,vol. 27, pp. 163- 195 ,(2007) , 10.2165/00044011-200727030-00002